If you look closely at what has become the new focus it is everything HIV. Combo bla, mono pivotal, PReP, cure and now Nash/fibrosis. In my opinion they are making the HIV side sexy as hell for any potential suitor knowing that the other indications are a little further away from approval. If Nash is effective leronlimab would be prescibed in any combo therapy and if Mono works the whole Market is cornered.